A Gap in Diagnosis of Hep C Infections During the Opioid Epidemic
Federally qualified health centers see 10 times the HCV prevalence of the general population, but aren’t yet reaching their full potential in fighting this consequence of the opioid epidemic.
Read MoreHealthcare Leaders on Institutional Response to Climate Change
Leaders and executives should seek “credible champions, manageable bites, and actionable solutions,” says Kate Walsh, CEO of Boston Medical Center. “This is the issue of our day.”
Read MorePolitics, Policy, and the Opioid Epidemic With Michael Botticelli
Decades after the failed War on Drugs was declared, policies for significant, systemic change remain slow to materialize.
Read MoreStudy: Improvements Needed for Hepatitis C Testing in Youth
The opioid epidemic is fueling an increase in hepatitis C in the Unites States, especially among younger demographics. Data from the Centers for Disease Control and Prevention (CDC) reveal that in 2016, 9.1% of all people with chronic hepatitis C virus (HCV) infection were between the ages of 15 and 24 — up from 3.8%…
Read MoreInfectious Disease Physicians Need a New Subspecialty: Addiction
Experts call for integrated subspecialty training that acknowledges the relationship between addiction and infectious disease.
Read MoreThe Public Charge Rule and the Hidden Impact on Public Health
Health and policy experts argue that changes to the public charge rule are a step in the wrong direction.
Read More